Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Spirometry | Research article

Reference value for expiratory time constant calculated from the maximal expiratory flow-volume curve

Authors: Takamitsu Ikeda, Yasuhiro Yamauchi, Kanji Uchida, Koji Oba, Takahide Nagase, Yoshitsugu Yamada

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

The expiratory time constant (RCEXP), which is defined as the product of airway resistance and lung compliance, enable us to assess the mechanical properties of the respiratory system in mechanically ventilated patients. Although RCEXP could also be applied to spontaneously breathing patients, little is known about RCEXP calculated from the maximal expiratory flow-volume (MEFV) curve. The aim of our study was to determine the reference value for RCEXP, as well as to investigate the association between RCEXP and other respiratory function parameters, including the forced expiratory volume in 1 s (FEV1)/ forced vital capacity (FVC) ratio, maximal mid-expiratory flow rate (MMF), maximal expiratory flow at 50 and 25% of FVC (MEF50 and MEF25, respectively), ratio of MEF50 to MEF25 (MEF50/MEF25).

Methods

Spirometric parameters were extracted from the records of patients aged 15 years or older who underwent pulmonary function testing as a routine preoperative examination before non-cardiac surgery at the University of Tokyo Hospital. RCEXP was calculated in each patient from the slope of the descending limb of the MEFV curve using two points corresponding to MEF50 and MEF25. Airway obstruction was defined as an FEV1/FVC and FEV1 below the statistically lower limit of normal.

Results

We retrospectively analyzed 777 spirometry records, and 62 patients were deemed to have airway obstruction according to Japanese spirometric reference values. The cut-off value for RCEXP was 0.601 s with an area under the receiver operating characteristic curve of 0.934 (95% confidence interval = 0.898–0.970). RCEXP was strongly associated with FEV1/FVC, and was moderately associated with MMF and MEF50. However, RCEXP was less associated with MEF25 and MEF50/MEF25.

Conclusions

Our findings suggest that an RCEXP of longer than approximately 0.6 s can be linked to the presence of airway obstruction. Application of the concept of RCEXP to spontaneously breathing subjects was feasible, using our simple calculation method.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brunner JX, Laubscher TP, Banner MJ, Iotti G, Braschi A. Simple method to measure total expiratory time constant based on the passive expiratory flow-volume curve. Crit Care Med. 1995;17:1117–22.CrossRef Brunner JX, Laubscher TP, Banner MJ, Iotti G, Braschi A. Simple method to measure total expiratory time constant based on the passive expiratory flow-volume curve. Crit Care Med. 1995;17:1117–22.CrossRef
2.
go back to reference Mead J. Analysis of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol. 1978;44:156–65.PubMed Mead J. Analysis of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol. 1978;44:156–65.PubMed
3.
go back to reference Lourens MS, van den Berg B, Aerts JG, Verbraak AF, Hoogsteden HC, Bogaard JM. Expiratory time constants in mechanically ventilated patients with and without COPD. Intensive Care Med. 2000;26(11):1612–8.CrossRef Lourens MS, van den Berg B, Aerts JG, Verbraak AF, Hoogsteden HC, Bogaard JM. Expiratory time constants in mechanically ventilated patients with and without COPD. Intensive Care Med. 2000;26(11):1612–8.CrossRef
4.
go back to reference Arnal JM, Garnero A, Saoli M, Chatburn RL. Parameters for simulation of adult subjects during mechanical ventilation. Respir Care. 2018;63(2):158–68.CrossRef Arnal JM, Garnero A, Saoli M, Chatburn RL. Parameters for simulation of adult subjects during mechanical ventilation. Respir Care. 2018;63(2):158–68.CrossRef
5.
go back to reference Arora VK, Raghu S. Flow volume curves: clinical significance. Lung India. 1996;14:169–71. Arora VK, Raghu S. Flow volume curves: clinical significance. Lung India. 1996;14:169–71.
6.
go back to reference Hyatt RE, Schilder DP, Fry DL. Relationship between maximum expiratory flow and degree of lung inflation. J Appl Physiol. 1958;13:331–6.CrossRef Hyatt RE, Schilder DP, Fry DL. Relationship between maximum expiratory flow and degree of lung inflation. J Appl Physiol. 1958;13:331–6.CrossRef
7.
go back to reference McIlroy MB, Tierney DF, Nadel JA. A new method of measurement of compliance and resistance of the lungs and thorax. J Appl Physiol. 1963;17:424–7.CrossRef McIlroy MB, Tierney DF, Nadel JA. A new method of measurement of compliance and resistance of the lungs and thorax. J Appl Physiol. 1963;17:424–7.CrossRef
8.
go back to reference Nemoto T, Shibata Y, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Nishiwaki M, Aida Y, Nunomiya K, Sato M, Watanabe T, Konta T, Kawata S, Kato T, Kayama T, Kubota I. Impact of cigarette smoking on maximal expiratory flows in a general population: the Takahata study. Intern Med. 2011;50:2547–55.CrossRef Nemoto T, Shibata Y, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Nishiwaki M, Aida Y, Nunomiya K, Sato M, Watanabe T, Konta T, Kawata S, Kato T, Kayama T, Kubota I. Impact of cigarette smoking on maximal expiratory flows in a general population: the Takahata study. Intern Med. 2011;50:2547–55.CrossRef
9.
go back to reference Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey DE Jr, Cross JT Jr, Fitterman N, Sherif KD, Weiss KB. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American college of physicians. Ann Intern Med. 2006;144(8):575–80.CrossRef Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey DE Jr, Cross JT Jr, Fitterman N, Sherif KD, Weiss KB. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American college of physicians. Ann Intern Med. 2006;144(8):575–80.CrossRef
10.
go back to reference Phunmanee A, Tuntisirin C, Zaeoue U. Preoperative spirometry to predict postoperative complications in thoracic surgery patients. J Med Assoc Thail. 2000;83(10):1253–9. Phunmanee A, Tuntisirin C, Zaeoue U. Preoperative spirometry to predict postoperative complications in thoracic surgery patients. J Med Assoc Thail. 2000;83(10):1253–9.
11.
go back to reference McFadden ER Jr, Linden DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med. 1972;52:725–7.CrossRef McFadden ER Jr, Linden DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med. 1972;52:725–7.CrossRef
12.
go back to reference The Committee of Pulmonary Physiology JRS. Forced expiratory curve, flow-volume curve and peak flow. In: The Clinical Respiratory Function Test 7th Edition. Medical Review, Tokyo, 2008 (in Japanese). The Committee of Pulmonary Physiology JRS. Forced expiratory curve, flow-volume curve and peak flow. In: The Clinical Respiratory Function Test 7th Edition. Medical Review, Tokyo, 2008 (in Japanese).
13.
go back to reference Ikeda T, Uchida K, Yamauchi Y, Oba K, Nagase T, Yamada Y. Relationship between pre-anesthetic and intra-anesthetic airway resistance in patients undergoing general anesthesia: a prospective observational study. PLoS One. 2012;12(2):e0172421.CrossRef Ikeda T, Uchida K, Yamauchi Y, Oba K, Nagase T, Yamada Y. Relationship between pre-anesthetic and intra-anesthetic airway resistance in patients undergoing general anesthesia: a prospective observational study. PLoS One. 2012;12(2):e0172421.CrossRef
14.
go back to reference The Japanese Respiratory Society. Spirometry and flow-volume curve. In: Guidelines for Pulmonary Function Testing. Medical Review, Tokyo, 2004 (in Japanese). The Japanese Respiratory Society. Spirometry and flow-volume curve. In: Guidelines for Pulmonary Function Testing. Medical Review, Tokyo, 2004 (in Japanese).
15.
go back to reference Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Investig. 2014;52(4):242–50.CrossRef Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Respir Investig. 2014;52(4):242–50.CrossRef
16.
go back to reference Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.CrossRef Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–51.CrossRef
17.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef
18.
go back to reference Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M. Clinical Pulmonary Functions Committee of the Japanese Respiratory Society. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52(4):242–50.CrossRef Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M. Clinical Pulmonary Functions Committee of the Japanese Respiratory Society. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52(4):242–50.CrossRef
19.
go back to reference Guttmann J, Eberhard L, Fabry B, Bertschmann W, Zeravik J, Adolph M, Eckart J, Wolff G. Time constant/volume relationship of passive expiration in mechanically ventilated ARDS patients. Eur Respir J. 1995;17:114–20.CrossRef Guttmann J, Eberhard L, Fabry B, Bertschmann W, Zeravik J, Adolph M, Eckart J, Wolff G. Time constant/volume relationship of passive expiration in mechanically ventilated ARDS patients. Eur Respir J. 1995;17:114–20.CrossRef
20.
go back to reference Kondilli E, Prinianakis H, Athanasakis D, Georgopoulos D. Lung emptying in patients with acute respiratory distress syndrome: effect of positive end expiratory pressure. Eur Respir J. 2002;17:811–9.CrossRef Kondilli E, Prinianakis H, Athanasakis D, Georgopoulos D. Lung emptying in patients with acute respiratory distress syndrome: effect of positive end expiratory pressure. Eur Respir J. 2002;17:811–9.CrossRef
21.
go back to reference Pierce JA. Studies of free collapse in the intact human lung. J Lab Clin Med. 1959;54:96–106.PubMed Pierce JA. Studies of free collapse in the intact human lung. J Lab Clin Med. 1959;54:96–106.PubMed
22.
go back to reference West JB. Pulmonary pathophysiology: the essentials, 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 10–2. West JB. Pulmonary pathophysiology: the essentials, 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 10–2.
23.
go back to reference West JB. Respiratory physiology: the essentials, 9th ed. Lippincott Williams & Wilkins, Philadelphia. 2012:118–9. West JB. Respiratory physiology: the essentials, 9th ed. Lippincott Williams & Wilkins, Philadelphia. 2012:118–9.
24.
go back to reference Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximal expiratory flow. J Appl Physiol. 1967;22:95–108.CrossRef Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximal expiratory flow. J Appl Physiol. 1967;22:95–108.CrossRef
25.
go back to reference Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow-a unifying concept. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:498–515.PubMed Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow-a unifying concept. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:498–515.PubMed
26.
go back to reference Elliott EA, Dawson SV. Test of wave-speed theory of flow limitation in elastic tubes. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:516–22.PubMed Elliott EA, Dawson SV. Test of wave-speed theory of flow limitation in elastic tubes. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:516–22.PubMed
27.
go back to reference Bar-Yishay E, Amirav I, Goldberg S. Comparison of maximal midexpiratory flow rate and forced expiratory flow at 50% of vital capacity in children. Chest. 2003;123:731–5.CrossRef Bar-Yishay E, Amirav I, Goldberg S. Comparison of maximal midexpiratory flow rate and forced expiratory flow at 50% of vital capacity in children. Chest. 2003;123:731–5.CrossRef
28.
go back to reference McNamara JJ, Castile RG, Glass GM, Fredberg JJ. Heterogeneous lung emptying during forced expiration. J Appl Physiol. 1987;63:1648–57.CrossRef McNamara JJ, Castile RG, Glass GM, Fredberg JJ. Heterogeneous lung emptying during forced expiration. J Appl Physiol. 1987;63:1648–57.CrossRef
29.
go back to reference Dominelli PB, Foster GE, Guenette JA, Haverkamp HC, Eves ND, Dominelli GS, Henderson WR, O'Donnell DE, Sheel AW. Quantifying the shape of the maximal expiratory flow-volume curve in mild COPD. Respir Physiol Neurobiol. 2015;219:30–5.CrossRef Dominelli PB, Foster GE, Guenette JA, Haverkamp HC, Eves ND, Dominelli GS, Henderson WR, O'Donnell DE, Sheel AW. Quantifying the shape of the maximal expiratory flow-volume curve in mild COPD. Respir Physiol Neurobiol. 2015;219:30–5.CrossRef
30.
go back to reference Fowler RW, Pluck RA, Hetzel MR. Maximal expiratory flow-volume curves in Londoners aged 60 years and over. Thorax. 1987;42:173–82.CrossRef Fowler RW, Pluck RA, Hetzel MR. Maximal expiratory flow-volume curves in Londoners aged 60 years and over. Thorax. 1987;42:173–82.CrossRef
31.
go back to reference Knudson RJ, Clark DF, Kennedy TC, Knudson DE. Effect of aging alone on mechanical properties of the normal adult human lung. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:1054–62.PubMed Knudson RJ, Clark DF, Kennedy TC, Knudson DE. Effect of aging alone on mechanical properties of the normal adult human lung. J Appl Physiol Respir Environ Exerc Physiol. 1977;43:1054–62.PubMed
32.
go back to reference Takishima T, Sasaki T, Takahashi K, Sasaki H, Nakamura T. Direct-writing recorder of the flow-volume curve and its clinical application. Chest. 1972;61:262–6.CrossRef Takishima T, Sasaki T, Takahashi K, Sasaki H, Nakamura T. Direct-writing recorder of the flow-volume curve and its clinical application. Chest. 1972;61:262–6.CrossRef
33.
go back to reference Sakamoto O, Saita N, Ando M, Kohrogi H, Suga M, Ando M. Two cases of Sjögren's syndrome with multiple bullae. Intern Med. 2002;41:124–8.CrossRef Sakamoto O, Saita N, Ando M, Kohrogi H, Suga M, Ando M. Two cases of Sjögren's syndrome with multiple bullae. Intern Med. 2002;41:124–8.CrossRef
Metadata
Title
Reference value for expiratory time constant calculated from the maximal expiratory flow-volume curve
Authors
Takamitsu Ikeda
Yasuhiro Yamauchi
Kanji Uchida
Koji Oba
Takahide Nagase
Yoshitsugu Yamada
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Spirometry
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0976-6

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.